| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159658 | The Journal of Urology | 2011 | 11 Pages |
Abstract
New pharmacotherapies and technologies have emerged which have impacted treatment algorithms. The management of LUTS/BPH continues to evolve.
Keywords
TUMTPSAtransurethral incision of the prostateIFISTUIPUTIIntraoperative floppy iris syndromeQOLQuality of lifeAdrenergic alpha-antagonistsProstate specific antigenurinary retentionErectile dysfunctionBladder outlet obstructionTransurethral resection of prostateTransurethral resection of the prostateBOOBehavior therapyCAMTURPurinary tract infectionLower urinary tract symptomsTuna5-alpha-reductase inhibitorsLUTSBenign prostatic hyperplasiaBPHProstatic hyperplasia
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kevin T. McVary, Claus G. Roehrborn, Andrew L. Avins, Michael J. Barry, Reginald C. Bruskewitz, Robert F. Donnell, Harris E. Jr., Chris M. Gonzalez, Steven A. Kaplan, David F. Penson, James C. Ulchaker, John T. Wei,